Company / Tangible Book Value per Share
Cullinan Therapeutics, Inc. Tangible Book Value per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$10.09
FY2024
5-year range
$10.07 / $14.25
FY2020-FY2024
Trend
-7.6%
vs FY2023
Sector context
#50 of 209
Health Care
What the data says
Cullinan Therapeutics, Inc.'s tangible book value per share of $10.09 is higher than 76% of companies in the Health Care sector (FY2024). Tangible Book Value per Share has declined for 3 consecutive years, from $14.25 in FY2021 to $10.09 in FY2024.
Based on SEC 10-K filings.
10.09 in FY2024 with a 3-year CAGR of -10.9%. Top quartile in the Health Care sector.
Declined from $11.68 to $10.09 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
-89.2% below sector average
Key checks
Key Insights
- Cullinan Therapeutics, Inc.'s tangible book value per share has declined for 3 consecutive years.
- In FY2024, tangible book value per share decreased 7.6% year-over-year.
- Ranks #50 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 7.33 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $10.09 | -7.6% |
| FY2023 | $10.92 | -6.5% |
| FY2022 | $11.68 | -18.0% |
| FY2021 | $14.25 | +41.4% |
| FY2020 | $10.07 | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026